Company: AIBT
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001096906-25-001895
Chunk: 25

Company: AIBOTICS, INC.
Filing Date: 2025-11-19
Form: 10-Q
Item: Item 8
Chunk 25
---
, respectively. As of September 30, 2025, the Company had an unamortized discount debt balance of $19,966.

NOTE 7 – STOCKHOLDERS’ EQUITY
 
As of December 31, 2023, the Company was authorized to issue 5,000,000 shares of its preferred stock in one or more series, of which 1,500,000 were designated “Series B Preferred Stock”. On June 24, 2024, the Board of Directors of the Company approved the designation of one share of preferred stock as “Series A Preferred Stock”. As of September 30, 2025, the Company was authorized to issue 5,000,000 shares of preferred stock, of which 1,500,000 were designated “Series B Preferred Stock” and 1 was designated “Series A Preferred Stock”.
 
As of September 30, 2025 and December 31, 2024 we were authorized to issue 467,000,000 shares of common stock, respectively. On June 24, 2024, the Board of Directors of the Company approved an increase in the authorized shares of common stock from 100,000,000 to 467,000,000.
 
Common Stock 
 
As of September 30, 2025, and December 31, 2024, we were authorized to issue 467,000,000 shares of common stock, respectively. Each share of common stock has a $0.001 par value. Each share of common stock entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought. The Company had 318,890,559 and 39,990,903 shares of common stock issued and outstanding as of September 30, 2025, and December 31, 2024, respectively.
 
During the nine months ended September 30, 2025, the Company issued 41,303,934 shares of common stock to settle accounts payable and accrued expenses, totaling $330,431. The fair value of the shares issued was based on the market price of the Company’s common stock on the respective issuance dates. The Company recognized a net non-cash loss on settlement of approximately $49,080, recorded within Other Income (Expense) in the condensed consolidated statements of operations. 
 
During the nine months ended September 30, 2025, the Company issued